Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-24 @ 9:59 PM
NCT ID:
NCT06272032
Eligibility Criteria:
Inclusion Criteria:
1. Refractory AR.
2. Patients exhibiting persistent mucosal hypersensitivity or high secretion state (rhinorrhea, sneezing, etc.).
Exclusion Criteria:
1. Patients with exacerbation of nasal symptoms, uncontrolled or acute exacerbation of asthma
2. Patients with bleeding tendency, coagulation disorders
3. Patients with poor overall condition, unable to tolerate procedures
4. Patients with severe cardiovascular diseases, immune system disorders, malignant tumors
5. Patients with psychological disorders or poor compliance, combined with primary immunological diseases (such as Sjögren's syndrome) or abnormal results of tear secretion tests, etc.
6. Patients under 18 years of age or over 70 years of age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT06272032
Study Brief:
Protocol Section:
NCT06272032